AF care ‘inadequate’

NewsGuard 100/100 Score

By Caroline Price

Cardiology experts are supporting a call for greater attention to diagnosis and management of atrial fibrillation (AF) in primary care to prevent strokes.

In a report produced for parliament, they say that GPs are still prescribing aspirin to patients with AF who are at high risk of stroke. Recent data from one area in England showed that over 40% of patients with a CHADS2 score of 2 or higher were not receiving warfarin. And, as reported by MedWire News at the time, another study suggested that instead of being more likely to recommend an anticoagulant, GPs are actually more likely to prescribe aspirin the higher a patient's stroke risk is (click here).

The Stroke in Atrial Fibrillation Expert (Safe) report was produced by a panel including cardiologists, GPs and patient groups and the Chair of the AF All-party Parliamentary Group, Glyn Davies MP.

One of the panelists, Dr Alan Begg, a GP in Montrose with a special interest in cardiology, commented: "It is extremely concerning that healthcare professionals often seem to be choosing the 'easy option' rather than better stroke protection. Even experienced doctors falsely believe they are fully protecting people by recommending aspirin."

Many patients with AF are going undiagnosed in the first place, partly because of patchy access to simple investigations such as ECGs, according to the report.

Another GP on the panel, Dr Mark Davis, said: "In Leeds most of our GPs' surgeries have an ECG monitor; however this is not necessarily the case across the rest of the UK. It is so much more convenient and cost effective for patients to be tested within their own GPs' surgeries."

The report, funded by the developers of dabigatran etexilate, Boehringer Ingelheim, also says that, despite NICE backing, novel oral anticoagulants are being underused. It claims many patients who may benefit from the new drugs - such as those unstable on warfarin - are not receiving them, due to "insufficient time to pass through local formulary committees and lack of local guidelines identifying appropriate patients", and because some PCTs have banned their use outright on the basis of cost.

GP News is an independent clinical news service provided by Springer Healthcare Limited. © Springer Healthcare Ltd; 2012

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Empowering Change: How Hologic is Shaping the Future of Women's Healthcare